Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus

被引：35

作者：

Schiffenbauer, J

Hahn, B

Weisman, MH

Simon, LS

机构：

[1] US FDA, CDER, Rockville, MD 20850 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

来源：

ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 08期

关键词：

D O I：

10.1002/art.20353

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2415 / 2422

页数：8

共 23 条

[1] LONGITUDINAL-STUDY ON THE PRODUCTION OF AND CELLULAR-RESPONSE TO INTERLEUKIN A IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

ALCOCERVARELA, J ;

ALARCONSEGOVIA, D .

RHEUMATOLOGY INTERNATIONAL, 1995, 15 (02) :57-63

[2] Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus [J].

Baechler, EC ;

Batliwalla, FM ;

Karypis, G ;

Gaffney, PM ;

Ortmann, WA ;

Espe, KJ ;

Shark, KB ;

Grande, WJ ;

Hughes, KM ;

Kapur, V ;

Gregersen, PK ;

Behrens, TW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2610-2615

[3] Treatment of lupus nephritis: A meta-analysis of clinical trials [J].

Bansal, VK ;

Beto, JA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (02) :193-199

[4] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].

BOMBARDIER, C ;

GLADMAN, DD ;

UROWITZ, MB ;

CARON, D ;

CHANG, CH .

ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640

[5] A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus [J].

DeGiorgio, LA ;

Konstantinov, KN ;

Lee, SC ;

Hardin, JA ;

Volpe, BT ;

Diamond, B .

NATURE MEDICINE, 2001, 7 (11) :1189-1193

[6]

DRAEGER AM, 1986, CLIN EXP IMMUNOL, V64, P80

[7] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus [J].

Gladman, D ;

Ginzler, E ;

Goldsmith, C ;

Fortin, P ;

Liang, M ;

Urowitz, M ;

Bacon, P ;

Bombardieri, S ;

Hanly, J ;

Hay, E ;

Isenberg, D ;

Jones, J ;

Kalunian, K ;

Maddison, P ;

Nived, O ;

Petri, M ;

Richter, M ;

SanchezGuerrero, J ;

Snaith, M ;

Sturfelt, G ;

Symmons, D ;

Zoma, A .

ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :363-369

[8] Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis - A randomized, controlled trial [J].

Gourley, MF ;

Austin, HA ;

Scott, D ;

Yarboro, CH ;

Vaughn, EM ;

Muir, J ;

Boumpas, DT ;

Klippel, JH ;

Balow, JE ;

Steinberg, AD .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :549-+

[9]

GUZMAN J, 1992, J RHEUMATOL, V19, P1551

[10] Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus [J].

Jacobi, AM ;

Odendahl, M ;

Reiter, K ;

Bruns, A ;

Burmester, GR ;

Radbruch, A ;

Valet, G ;

Lipsky, PE ;

Dörner, T .

ARTHRITIS AND RHEUMATISM, 2003, 48 (05) :1332-1342

← 1 2 3 →